Cargando…

Chemotherapy promotes astrocytic response to Aβ deposition, but not Aβ levels, in a mouse model of amyloid and APOE

Many cancer survivors experience cancer-related cognitive impairment (CRCI), which is characterized by problems of attention, working memory, and executive function following chemotherapy and/or hormonal treatment. APOE4, the strongest genetic risk factor for Alzheimer’s Disease (AD), is also a risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ng, Christi Anne S., Biran, Lucas P., Galvano, Elena, Mandelblatt, Jeanne, Vicini, Stefano, Rebeck, G. William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794416/ https://www.ncbi.nlm.nih.gov/pubmed/36336241 http://dx.doi.org/10.1016/j.nbd.2022.105915

Ejemplares similares

3367 A Mouse Model of APOE Genotype in Chemotherapy Related Cognitive Impairment
por: Demby, Tamar, et al.
Publicado: (2019)

Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition
por: Rodriguez, Gustavo A, et al.
Publicado: (2014)

Behavioral and transcriptomic effects of the cancer treatment tamoxifen in mice
por: Galvano, Elena, et al.
Publicado: (2023)

ApoE Lipidation as a Therapeutic Target in Alzheimer’s Disease
por: Lanfranco, Maria Fe, et al.
Publicado: (2020)

Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders
por: Batarseh, Yazan S., et al.
Publicado: (2016)

Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk
por: Tai, Leon M, et al.
Publicado: (2014)

Garcinoic acid prevents β-amyloid (Aβ) deposition in the mouse brain
por: Marinelli, Rita, et al.
Publicado: (2020)

Astrocytic function is associated with both amyloid-β and tau pathology in non-demented APOE ϵ4 carriers
por: Spotorno, Nicola, et al.
Publicado: (2022)

Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia
por: Salvadó, Gemma, et al.
Publicado: (2021)

ApoE Alzheimer’s Disease Aβ-amyloid plaque morphology varies according to APOE isotype
por: Caesar, Ina, et al.
Publicado: (2023)

ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice
por: Button, Emily B., et al.
Publicado: (2019)

Molecular modeling of apoE in complexes with Alzheimer’s amyloid-β fibrils from human brain suggests a structural basis for apolipoprotein co-deposition with amyloids
por: Lewkowicz, Emily, et al.
Publicado: (2023)

Characterization of Amyloid-β Deposits in Bovine Brains
por: Vallino Costassa, Elena, et al.
Publicado: (2016)

ApoE mimetic peptide decreases Aβ production in vitro and in vivo
por: Minami, S Sakura, et al.
Publicado: (2010)

Effects and mechanism of amyloid β(1-42) on mitochondria in astrocytes
por: Yao, Yunyi, et al.
Publicado: (2018)

The reduction of astrocytic tau prevents amyloid-β-induced synaptotoxicity
por: Cisternas, Pablo, et al.
Publicado: (2022)

Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor APOE
por: Fernandez, Harvey R., et al.
Publicado: (2020)

Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition
por: Kantarci, Kejal, et al.
Publicado: (2016)

Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis
por: Kim, Jungsu, et al.
Publicado: (2012)

Phosphorylation modifies the molecular stability of β-amyloid deposits
por: Rezaei-Ghaleh, Nasrollah, et al.
Publicado: (2016)

IKK2/NF-κB Activation in Astrocytes Reduces amyloid β Deposition: A Process Associated with Specific Microglia Polarization
por: Yang, Shu, et al.
Publicado: (2021)

Early Detection of Aβ Deposition in the 5xFAD Mouse by Amyloid PET
por: Oh, Se Jong, et al.
Publicado: (2018)

Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information
por: Insel, Philip S., et al.
Publicado: (2016)

APOEε4 potentiates the relationship between amyloid-β and tau pathologies
por: Therriault, Joseph, et al.
Publicado: (2020)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
por: Fandos, Noelia, et al.
Publicado: (2017)

The Mitochondrial Enzyme 17βHSD10 Modulates Ischemic and Amyloid-β-Induced Stress in Primary Mouse Astrocytes
por: Metodieva, Vanya, et al.
Publicado: (2022)

Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis
por: Mahan, Thomas E., et al.
Publicado: (2022)

APOE-ε4 synergizes with sleep disruption to accelerate Aβ deposition and Aβ-associated tau seeding and spreading
por: Wang, Chanung, et al.
Publicado: (2023)

Amyloid-β Impairs Vesicular Secretion in Neuronal and Astrocyte Peptidergic Transmission
por: Plá, Virginia, et al.
Publicado: (2017)

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
por: Ferrari-Souza, João Pedro, et al.
Publicado: (2022)

Aβ43 levels determine the onset of pathological amyloid deposition
por: Tambini, Marc D., et al.
Publicado: (2023)

Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model
por: Huynh, Tien-Phat V., et al.
Publicado: (2019)

Preventing β-amyloid fibrillization and deposition: β-sheet breakers and pathological chaperone inhibitors
por: Wisniewski, Thomas, et al.
Publicado: (2008)

Neuronal activity regulates the regional vulnerability to amyloid-β deposition
por: Bero, Adam W., et al.
Publicado: (2011)

Neural compensation in older people with brain β-amyloid deposition
por: Elman, Jeremy A., et al.
Publicado: (2014)

Dietary patterns and β-amyloid deposition in aging Australian women
por: Hill, Edward, et al.
Publicado: (2018)

Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
por: Baek, Min Seok, et al.
Publicado: (2020)

Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid
por: Lim, Yen Ying, et al.
Publicado: (2021)

Progranulin Protects against Amyloid β Deposition and Toxicity in Alzheimer’s Disease Mouse Models
por: Minami, S. Sakura, et al.
Publicado: (2014)

Amyloid deposition and ApoE4 carriers in idiopathic normal pressure hydrocephalus
por: Bundo, Masahiko, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0ch6odqlf9mvpl6n60v2dt2p76